Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Industriels
  2. Médicament
  3. ARTELAC (hypromellose)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

ARTELAC (hypromellose)

Medicine - Posted on Oct 25 2018 - Updated on Jun 12 2019
Active substance (DCI)
  • hypromellose
history (4)
  • 10/3/18

    ARTELAC (hypromellose)

    Maintien du remboursement dans les mêmes conditions.
    icône flèche
  • 5/15/13

    ARTELAC (hypromellose)

    ARTELAC (hypromellose)
    icône flèche
  • 3/5/08

    ARTELAC (hypromellose)

    ARTELAC (hypromellose)
    icône flèche
  • 3/19/03

    ARTELAC 1,6 mg/0,5 ml, collyre en solution en récipient unidose (boîte de 60)

    ARTELAC 1,6 mg/0,5 ml, collyre en solution en récipient unidose (boîte de 60)
    CAV :
    54321
    icône flèche
Technical information
ATC code
  • S01XA20
Manufacturer
CHAUVIN
Presentation

ARTELAC 1,6 mg/0,5 ml, collyre en récipient unidose (code CIS : 65042132) - 60 récipients unidoses de 0,5 ml - Code CIP : 3400934035890

All our publications
    Drug therapy Eye diseases

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
JrtFcNVyFGFNVWxC